HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Critical role of PAFR/YAP1 positive feedback loop in cardiac fibrosis.

Abstract
Aberrant activation of cardiac fibroblasts is the main cause and character of cardiac fibrosis, and inhibition of cardiac fibrosis becomes a promising treatment for cardiac diseases. Platelet-activating factor (PAF) and Hippo pathway is recently recognized as key signaling mechanisms in cardiovascular diseases. In this study we explored the potential roles of PAF and Hippo signaling pathway in cardiac fibrosis. Myocardial infarction (MI) was induced in mice by left anterior descending artery ligation. After 28 days, the mice were sacrificed, and the hearts were collected for analyses. We showed that PAF receptor (PAFR) and yes-associated protein 1 (YAP1, a key effector in the Hippo pathway) were significantly increased in the heart of MI mice. Increased expression of PAFR and YAP1 was also observed in angiotensin II (Ang II)-treated mouse cardiac fibroblasts. In mouse cardiac fibroblasts, forced expression of YAP1 increased cell viability, resulted in collagen deposition and promoted fibroblast-myofibroblast transition. We showed that PAF induced fibrogenesis through activation of YAP1 and promoted its nuclear translocation via interacting with PAFR, while YAP1 promoted the expression of PAFR by binding to and activating transcription factor TEAD1. More importantly, silencing PAFR or YAP1 by shRNA, or using transgenic mice to induce the conditional deletion of YAP1 in cardiac fibroblasts, impeded cardiac fibrosis and improved cardiac function in MI mice. Taken together, this study elucidates the role and mechanisms of PAFR/YAP1 positive feedback loop in cardiac fibrosis, suggesting a potential role of this pathway as novel therapeutic targets in cardiac fibrosis.
AuthorsTian-Yu Li, Wei Su, Liang-Liang Li, Xiao-Guang Zhao, Na Yang, Jia-Xin Gai, Xin Lv, Jing Zhang, Meng-Qin Huang, Qing Zhang, Wei-Hang Ji, Xiao-Ying Song, Yu-Hong Zhou, Xue-Lian Li, Hong-Li Shan, Hai-Hai Liang
JournalActa pharmacologica Sinica (Acta Pharmacol Sin) Vol. 43 Issue 11 Pg. 2862-2872 (Nov 2022) ISSN: 1745-7254 [Electronic] United States
PMID35396533 (Publication Type: Journal Article)
Copyright© 2022. The Author(s), under exclusive licence to Shanghai Institute of Materia Medica, Chinese Academy of Sciences and Chinese Pharmacological Society.
Chemical References
  • Platelet Activating Factor
Topics
  • Mice
  • Animals
  • Feedback
  • Platelet Activating Factor
  • Signal Transduction (physiology)
  • Fibroblasts (metabolism)
  • Myocardial Infarction (metabolism)
  • Mice, Transgenic
  • Fibrosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: